Ya-Yu Tsai

4.4k total citations
72 papers, 1.0k citations indexed

About

Ya-Yu Tsai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Ya-Yu Tsai has authored 72 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 21 papers in Genetics. Recurrent topics in Ya-Yu Tsai's work include Brain Metastases and Treatment (34 papers), Glioma Diagnosis and Treatment (20 papers) and Lung Cancer Research Studies (16 papers). Ya-Yu Tsai is often cited by papers focused on Brain Metastases and Treatment (34 papers), Glioma Diagnosis and Treatment (20 papers) and Lung Cancer Research Studies (16 papers). Ya-Yu Tsai collaborates with scholars based in United States, China and Taiwan. Ya-Yu Tsai's co-authors include Prakash Chinnaiyan, Kamran A. Ahmed, Arnold B. Etame, Nicholas Figura, Jacob G. Scott, Sarah E. Hoffe, Peter Forsyth, Anthony F. Prestigiacomo, Hyo S. Han and Hatem Soliman and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Ya-Yu Tsai

68 papers receiving 1.0k citations

Peers

Countries citing papers authored by Ya-Yu Tsai

Since Specialization

Citations

This map shows the geographic impact of Ya-Yu Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Yu Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Yu Tsai more than expected).

Fields of papers citing papers by Ya-Yu Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Yu Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Yu Tsai. The network helps show where Ya-Yu Tsai may publish in the future.

Co-authorship network of co-authors of Ya-Yu Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Yu Tsai. A scholar is included among the top collaborators of Ya-Yu Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Yu Tsai. Ya-Yu Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma 2025 ·Neuro-Oncology ·Antonio Omuro, Lisa M. DeAngelis, Mei‐Yin C. Polley, Denise D. Correa, Jeffrey S. Wefel, Joseph Bovi, Marc Rosenblum, Benjamin W. Corn, Sanjay Aneja, (unknown), David M. Peereboom, Enrico C. Lallana, Maria Werner‐Wasik, Leland Rogers, Fábio M. Iwamoto, Ya-Yu Tsai, Eric D. Donnelly, (unknown), Minhee Won, Minesh P. Mehta	0
2	A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Solmaz Sahebjam, Ya-Yu Tsai, Dung‐Tsa Chen, (unknown), Heiko Enderling	1
3	Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery 2024 ·Journal of Neuro-Oncology ·(unknown), Matthew N. Mills, (unknown), (unknown), Nikhil I. Khushalani, Peter Forsyth, Michael A. Vogelbaum, Evan Wuthrick, Ya-Yu Tsai, Daniel Oliver, James K. Liu, Kamran A. Ahmed	4
4	MODL-06. THE GUT MICROBIOTA OF BRAIN TUMOR PATIENTS CAN IMPACT IMMUNOTHERAPY EFFICACY IN A PRECLINICAL MODEL OF GLIOMA 2023 ·Neuro-Oncology ·(unknown), (unknown), (unknown), (unknown), Dongquan Chen, Casey D. Morrow, (unknown), Burt Nabors, (unknown), Antonio Dono, Yoshua Esquenazi, Peter Forsyth, Ya-Yu Tsai, Nikhil I. Khushalani, Kathleen M. Egan, (unknown)	3
5	Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases 2023 ·European Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Youngchul Kim, (unknown), Nikhil I. Khushalani, Peter Forsyth, Arnold B. Etame, James K. Liu, Nam Tran, Michael A. Vogelbaum, Evan Wuthrick, Ya-Yu Tsai, Daniel Oliver, Kamran A. Ahmed	9
6	Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer 2023 ·Frontiers in Immunology ·Ya-Yu Tsai, Chenxu Qu, Joseph D. Bonner, Rebeca Sanz‐Pamplona, (unknown), Marilena Melas, Kevin McDonnell, Gregory Idos, Christopher Walker, (unknown), Diane M. Da Silva, Ferrán Moratalla-Navarro, Asaf Maoz, Hedy S. Rennert, W. Martin Kast, Joel K. Greenson, Vı́ctor Moreno, Gad Rennert, Stephen B. Gruber, Stephanie L. Schmit	3
7	Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions 2023 ·Cancers ·John Michael Bryant, (unknown), Joseph Weygand, (unknown), (unknown), Jacqueline M. Andreozzi, (unknown), Gage Redler, Kujtim Latifi, (unknown), Stephen A. Rosenberg, Ya-Yu Tsai, Daniel Oliver	5
8	How I treat brain metastases of melanoma 2022 ·ESMO Open ·Zeynep Eroglu, (unknown), Ya-Yu Tsai, Kim Margolin	4
9	The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs 2021 ·Breast Cancer Research and Treatment ·Matthew N. Mills, (unknown), Yuki Kawahara, (unknown), Nicholas Figura, Aixa Soyano, (unknown), Roberto Díaz, Daniel Oliver, Ya-Yu Tsai, Arnold B. Etame, Michael A. Vogelbaum, Brian J. Czerniecki, John A. Arrington, Solmaz Sahebjam, Peter Forsyth, Hatem Soliman, Hyo S. Han, Kamran A. Ahmed	8
10	Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases 2021 ·Journal of Neuro-Oncology ·Matthew N. Mills, (unknown), Nicholas Figura, Daniel Oliver, Aixa Soyano, Arnold B. Etame, Timothy J. Robinson, James K. Liu, Michael A. Vogelbaum, Peter Forsyth, Brian J. Czerniecki, Hatem Soliman, Hyo S. Han, Ya-Yu Tsai, Kamran A. Ahmed	8
11	Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements 2021 ·Scientific Reports ·Sarah C. Brüningk, Jeffrey Peacock, Christopher J. Whelan, Renee Brady‐Nicholls, Ya-Yu Tsai, Solmaz Sahebjam, Heiko Enderling	20
12	Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy 2019 ·Breast Cancer Research and Treatment ·Nicholas Figura, (unknown), Homan Mohammadi, Brittany Evernden, Sepideh Mokhtari, Ya-Yu Tsai, Timothy J. Robinson, Arnold B. Etame, Nam Tran, James K. Liu, (unknown), Roberto Díaz, Brian J. Czerniecki, Hatem Soliman, Hyo S. Han, Solmaz Sahebjam, Peter Forsyth, Kamran A. Ahmed	28
13	Patient-reported outcomes: using ESAS to screen for anemia 2019 ·Supportive Care in Cancer ·Peter A.S. Johnstone, (unknown), Ya-Yu Tsai, Diane Portman, (unknown), Ross Mitchell, Heather Jim	5
14	Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-β1 (TGF-β1) 2018 ·PLoS ONE ·Jung‐Pan Wang, Ya-Yu Tsai, En‐Rung Chiang, Jir‐You Wang, (unknown), Shih‐Chieh Hung	6
15	Effect of Ginkgo biloba extract on matrix metalloproteinase-3 expression in a rat model of chondrocyte injury 2015 ·Genetics and Molecular Research ·(unknown), (unknown), Hui Meng, Ya-Yu Tsai, Yukun Zhang, Ai Guo	8
16	Chloroquine Improves Survival and Hematopoietic Recovery After Lethal Low-Dose-Rate Radiation 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Yiting Lim, Mohammad Hedayati, Akil Merchant, Yonggang Zhang, Ya-Yu Tsai, Michael B. Kastan, William Matsui, Theodore L. DeWeese	9
17	Recapitulation of Fibromatosis Nodule by Multipotential Stem Cells in Immunodeficient Mice 2011 ·PLoS ONE ·(unknown), (unknown), Shih‐Tien Wang, Ya-Yu Tsai, (unknown), En-Rung Chiang, Chien-Lin Liu, Tain-Hsiung Chen, Shih‐Chieh Hung	5
18	Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma 2011 ·Neuro-Oncology ·Prakash Chinnaiyan, Sajeel Chowdhary, (unknown), Antony Prabhu, Ya-Yu Tsai, Bhaswati Sarcar, Soumen Kahali, Steven Brem, Ya-Yu Tsai, Amyn M. Rojiani, Ryan Murtagh, Edward Pan	56
19	Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer 2010 ·Cancer Research ·Ernest K. Amankwah, Qinggang Wang, Ya-Yu Tsai, Brooke L. Fridley, Jonathan Beesley, Sharon E. Johnatty, Penelope M. Webb, Georgia Chenevix‐Trench, Catherine M. Phelan, Julie M. Cunningham, Celine M. Vachon, Robert A. Vierkant, Edwin S. Iversen, Andrew Berchuck, Joellen M. Schildkraut, Ellen L. Goode, Thomas A. Sellers, Linda E. Kelemen	0
20	Perineural Invasion Affects Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Definitive External Beam Radiotherapy 2007 ·Urology ·Ya-Yu Tsai, Danny Y. Song, Ya-Yu Tsai, (unknown), Deborah A. Frassica, Theodore L. DeWeese	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact